Baird On Bed Bath & Beyond's Stock: 'Worth A Shot'

Retail executives face an uphill battle in succeeding in a turnaround plan but a bullish stance on Bed Bath & Beyond Inc. BBBY is "worth a shot," according to Baird.

The Analyst: Peter Benedict upgraded Bed Bath & Beyond's stock from Neutral to Outperform with a price target lifted from $13 to $20.

The Thesis: Bed Bath & Beyond CEO Mark Tritton deserves credit for overhauling the C-suite by bringing in omni-channel and business transformation experts, Benedict wrote in the note. Tritton is expected to explain his full turnaround around at an October investor meeting, but early indications favor a chance at overseeing a successful turnaround.

Related Link: Bed Bath & Beyond Reports Q1 Earnings Miss After Pandemic Store Closures

Meanwhile, early signs of "real change" are evident, including improvements over its private/owned brands, vendor renegotiation and data-driven assortment optimization. Consumers are also reacting well to a refreshed website experience, buy-online-pickup-in-store and curbside options. Renewed traction with customers could improve in 2021 and beyond from "meaningful" catalysts like store remodels.

Benedict said the company also proceeding with a cost savings program and potential asset sales that will help drive $335 million or more of profit improvement over the next two to three years.

Finally, more than 80% of analysts hold a neutral or bearish stance on Bed Bath & Beyond's stock while the market is assigning a minimal probability of success. This creates an "intriguing setup" and even if the company falls 50% short of its $800 million EBITDA target, the stock still has an upside potential of 50%

BBBY Price Action: Shares of Bed Bath & Beyond were trading higher by 5.7% at $14.12.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsBairdPeter Benedictretailretailersturnaround
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!